Most of them are in vitro studies performed on the scarcely differentiated MDA-MB-231 and MDA-MB-453 cell lines, representing the most used models of triple negative breast cancer (Figure 2), since they lack estrogen and progesterone receptors (ER and PR) and do not overexpress Her2 receptor. Here, PGR is linked to triple-negative breast carcinoma.